Literature DB >> 17407511

Overactive bladder syndrome in older people.

Adrian S Wagg1, Linda Cardozo, Christopher Chapple, Dirk De Ridder, Con Kelleher, Michael Kirby, Ian Milsom, Mark Vierhout.   

Abstract

The overactive bladder symptom complex (OAB) is the commonest cause of urinary incontinence in older people, and is usually due to underlying detrusor overactivity, and as such is a treatable condition. Older people are a heterogeneous group, which includes fit community-dwelling individuals and those with significant medical comorbidity; thus the requirements of care for this group are many and varied. The International Continence Society definition of the frail elderly, those aged >65 years with continence problems, who by virtue of comorbidity are house-bound or living in an institution, is clearly not applicable to all. However, many conditions begin to appear in later life and practitioners need to be aware of the need to manage these, and their treatment, when dealing with older people. Studies of medication for OAB have included the elderly and there is evidence of an equivalent benefit in younger people. The impact of treatment on the cognitively impaired and those receiving acetylcholinesterase inhibitors is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17407511     DOI: 10.1111/j.1464-410X.2006.06677.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  19 in total

1.  Overactive Bladder Is Strongly Associated With Frailty in Older Individuals.

Authors:  Anne M Suskind; Kathryn Quanstrom; Shoujun Zhao; Mark Bridge; Louise C Walter; John Neuhaus; Emily Finlayson
Journal:  Urology       Date:  2017-05-11       Impact factor: 2.649

2.  2012 update: guidelines for adult urinary incontinence collaborative consensus document for the canadian urological association.

Authors:  Mathieu Bettez; Le Mai Tu; Kevin Carlson; Jacques Corcos; Jerzy Gajewski; Martine Jolivet; Greg Bailly
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

3.  Treating overactive bladder in the elderly.

Authors:  Adrian Wagg
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

Review 4.  Treatment of Overactive Bladder in the Elderly Female: The Case for Trospium, Oxybutynin, Fesoterodine and Darifenacin.

Authors:  Scott C McFerren; Alex Gomelsky
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923

5.  Randomized controlled trial of cyclic and continuous therapy with trospium and solifenacin combination for severe overactive bladder in elderly patients with regard to patient compliance.

Authors:  Kirill V Kosilov; Sergay A Loparev; Marina A Ivanovskaya; Liliya V Kosilova
Journal:  Ther Adv Urol       Date:  2014-12

6.  Urgency urinary incontinence in women 50 years or older: incidence, remission, and predictors of change.

Authors:  Yuko M Komesu; Ronald M Schrader; Rebecca G Rogers; Loren H Ketai
Journal:  Female Pelvic Med Reconstr Surg       Date:  2011-01       Impact factor: 2.091

7.  Caffeine as a Probable Factor for Increased Risk of OAB Development in Elderly People.

Authors:  Kirill V Kosilov; Sergay A Loparev; Marina A Ivanovskaya; Liliya V Kosilova
Journal:  Curr Urol       Date:  2016-09-20

8.  Antimuscarinic Medication Use in Elderly Patients with Overactive Bladder.

Authors:  Nandita Kachru; Sneha Sura; Satabdi Chatterjee; Rajender R Aparasu
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

Review 9.  OnabotulinumtoxinA Treatment for Overactive Bladder in the Elderly: Practical Points and Future Prospects.

Authors:  Hann-Chorng Kuo
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

10.  Oxybutynin extended release for the management of overactive bladder: a clinical review.

Authors:  A M Arisco; E K Brantly; S R Kraus
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.